Home › Funds › PARUS FINANCE (UK) Ltd › CVS

PARUS FINANCE (UK) Ltd position in CVS

CVS HEALTH CORP · Consumer Staples

PARUS FINANCE (UK) Ltd reported holding 63,399 shares of CVS (CVS HEALTH CORP) in its Q2 2026 13F filing — a position valued at US$6.6M, representing 1.71% of its reported portfolio and ranking #16 among its reported holdings. PARUS FINANCE (UK) Ltd has disclosed CVS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)63.40K sh
Reported value held$6.56M
Portfolio Weight1.71%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How PARUS FINANCE (UK) Ltd's CVS position evolved

PARUS FINANCE (UK) Ltd first disclosed a stake in CVS in Q3 2023 at 159,111 shares (US$11.1M). The position peaked in Q4 2023 at 173,175 shares, worth US$13.7M. Across 12 filings, PARUS FINANCE (UK) Ltd increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 63,399 shares valued at US$6.6M — an increase of 560 shares quarter over quarter.. Notable position changes include a 27% trim in Q3 2024 (shares fell 28% over the following quarter), a 35% trim in Q3 2025 (shares rose 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 159.11K $11.11M New
Q4 2023 173.18K $13.67M Add
Q1 2024 151.69K $12.10M Reduce
Q2 2024 153.18K $9.05M Add
Q3 2024 111.16K $6.99M Reduce
Q4 2024 108.53K $4.87M Reduce
Q1 2025 102.36K $6.93M Reduce
Q2 2025 98.44K $6.79M Reduce
Q3 2025 64.15K $4.84M Reduce
Q4 2025 64.15K $5.09M Hold
Q1 2026 62.84K $4.51M Reduce
Q2 2026 63.40K $6.56M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CVS and 13F data

CVS (CVS HEALTH CORP) is a Consumer Staples company. 39 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$7.75B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CVS

All CVS fund holders →

FAQ

How long has PARUS FINANCE (UK) Ltd held CVS?

PARUS FINANCE (UK) Ltd has disclosed CVS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is PARUS FINANCE (UK) Ltd's current position in CVS?

As of Q2 2026, PARUS FINANCE (UK) Ltd holds 63.40K shares of CVS (CVS HEALTH CORP), valued at $6.56M, representing 1.71% of its reported portfolio and ranking #16.

Has PARUS FINANCE (UK) Ltd been buying or selling CVS?

In the latest 13F filing (Q2 2026), PARUS FINANCE (UK) Ltd increased its position in CVS. The position peaked in Q4 2023 at 173.18K shares.

Which other funds hold CVS?

Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.